|
1
|
Ali A and Ahmed S: A review on chitosan
and its nanocomposites in drug delivery. Int J Biol Macromol.
109:273–286. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kurita K, Koyama Y, Inoue S and Nishimura
S: ((Diethylamino) ethyl) chitins: Preparation and properties of
novel aminated chitin derivatives. Macromolecules. 23:2865–9. 1990.
View Article : Google Scholar
|
|
3
|
Andrew CA, Khor E and Hastings GW: The
influence of anionic chitin derivatives on calcium phosphate
crystallization. Biomaterials. 19:1309–1316. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu X, Gu X, Sun J and Zhang S:
Preparation and characterization of chitosan derivatives and their
application as flame retardants in thermoplasticn polyurethane.
Carbohydr Polym. 167:356–363. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fonseca-Santos B and Chorilli M: An
overview of carboxymethyl derivatives of chitosan: Their use as
biomaterials and drug delivery systems. Mater Sci Eng C Mater Biol
Appl. 77:1349–1362. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Abdel-Latif M, El-Shahawi G, Aboelhadid SM
and Abdel-Tawab H: Immunoprotective effect of Chitosan particles on
hymenolepis nana-infected mice. Scand J Immunol. 86:83–90. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Comblain F, Rocasalbas G, Gauthier S and
Henrotin Y: Chitosan: A promising polymer for cartilage repair and
viscosupplementation. Biomed Mater Eng. 28:S209–S215.
2017.PubMed/NCBI
|
|
8
|
Yar M, Shahzad S, Shahzadi L, Shahzad SA,
Mahmood N, Chaudhry AA, Rehman U and MacNeil S: Heparin binding
chitosan derivatives for production of pro-angiogenic hydrogels for
promoting tissue healing. Mater Sci Eng C Mater Biol Appl.
74:347–356. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ming Guo and Yanfei Ma: Synthesis,
anti-oxidant activity, and biodegradability of a novel recombinant
polysaccharide derived from chitosan and lactose. Carbohydrate
Polymers. 118:218–223. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dey A and Cederbaum AI: Alcohol and
oxidative liver injury. Hepatology. 43:S63–S74. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sun KH, Chang Y, Reed NI and Sheppard D:
α-Smooth muscle actin is an inconsistent marker of fibroblasts
responsible for force-dependent TGFβ activation or collagen
production across multiple models of organ fibrosis. Am J Physiol
Lung Cell Mol Physiol. 310:L824–L836. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Iwaisako K, Jiang C, Zhang M, Cong M,
Moore-Morris TJ, Park TJ, Liu X, Xu J, Wang P, Paik YH, et al:
Origin of myofibroblasts in the fibrotic liver in mice. Proc Natl
Acad Sci USA. 111:E3297–E3305. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hong IH, Park SJ, Goo MJ, Lee HR, Park JK,
Ki MR, Kim SH, Lee EM, Kim AY and Jeong KS: JNK1 and JNK2 regulate
α-SMA in hepatic stellate cells during CCl4-induced fibrosis in the
rat liver. Pathol Int. 63:483–491. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Baroni Svegliati G, D'Ambrosio L, Ferretti
G, Casini A, Di Sario A, Salzano R, Ridolfi F, Saccomanno S,
Jezequel AM and Benedetti A: Fibrogenic effect of oxidative stress
on rat hepatic stellate cells. Hepatology. 27:720–726. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ghatak S, Biswas A, Dhali GK, Chowdhury A,
Boyer JL and Santra A: Oxidative stress and hepatic stellate cell
activation are key events in arsenic induced liver fibrosis in
mice. Toxicol Appl Pharmacol. 251:59–69. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Peng L, Jia X, Zhao J, Cui R and Yan M:
Substance P promotes hepatic stellate cell proliferation and
activation via the TGF-β1/Smad-3 signaling pathway. Toxicol Appl
Pharmacol. 329:293–300. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lee YS, Kim SY, Ko E, Lee JH, Yi HS, Yoo
YJ, Je J, Suh SJ, Jung YK and Kim JH: Exosomes derived from
palmitic acid-treated hepatocytes induce fibrotic activation of
hepatic stellate cells. Sci Rep. 7:37102017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Friedman SL: Liver fibrosis-from bench to
bedside. J Hepatol. 38 Suppl 1:S38–S53. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang L, Feng Y, Ma X, Wang G, Wu H, Xie X,
Zhang C and Zhu Q: Diagnostic efficacy of noninvasive liver
fibrosis indexes in predicting portal hypertension in patients with
cirrhosis. PLoS One. 12:e01829692017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chang CC, Lee WS, Chuang CL, Hsin IF, Hsu
SJ, Chang T, Huang HC, Lee FY and Lee SD: Effects of raloxifene on
portal hypertension and hepatic encephalopathy in cirrhotic rats.
Eur J Pharmacol. 802:36–43. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Brunt EM, Janney CG, Di Bisceglie AM,
Neuschwander-Tetri BA and Bacon BR: Nonalcoholic steatohepatitis: A
proposal for grading and staging the histological lesions. Am J
Gastroenterol. 94:2467–2474. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kleiner DE, Brunt EM, Van Natta M, Behling
C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS,
Unalp-Arida A, et al: Design and validation of a histological
scoring system for nonalcoholic fatty liver disease. Hepatology.
41:1313–1321. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li M, Wang XF, Shi JJ, Li YP, Yang N, Zhai
S and Dang SS: Caffeic acid phenethyl ester inhibits liver fibrosis
in rats. World J Gastroenterol. 21:3893–3903. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Subhapradha N, Saravanan R, Saravanan P,
Srinivasan A, Shanmugam V and Shanmugam A: Hepatoprotective effect
of β-chitosan from gladius of Sepioteuthis lessoniana against
carbon tetrachloride-induced oxidative stress in Wistar rats. Appl
Biochem Biotechnol. 172:9–20. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ramasamy P, Subhapradha N, Shanmugam V and
Shanmugam A: Protective effect of chitosan from Sepia kobiensis
(Hoyle 1885) cuttlebone against CCl4 induced hepatic injury. Int J
Biol Macromol. 65:559–563. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ozcelik E, Uslu S, Erkasap N and Karimi H:
Protective effect of chitosan treatment against
acetaminophen-induced hepatotoxicity. Kaohsiung J Med Sci.
30:286–290. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bai Q, Yan H, Sheng Y, Jin Y, Shi L, Ji L
and Wang Z: Long-term acetaminophen treatment induced liver
fibrosis in mice and the involvement of Egr-1. Toxicology.
382:47–58. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Natarajan K, Singh S, Burke TR Jr,
Grunberger D and Aggarwal BB: Caffeic acid phenethyl ester is a
potent and specific inhibitor of activation of nuclear
transcription factor NF-kappa B. Proc Natl Acad Sci USA.
93:9090–9095. 1996. View Article : Google Scholar : PubMed/NCBI
|
